Genetic origin of patients having spastic paraplegia with or without other neurologic manifestations
Authors:
Open Access
- 16 May 2022
- journal article
- research article
- Published by Springer Nature in BMC Neurology
- Vol. 22 (1) , 1-14
Abstract
Background: Hereditary spastic paraplegia (HSP) is a group of neurodegenerative diseases characterized by lower-limb spastic paraplegia with highly genetic and clinical heterogeneity. However, the clinical sign of spastic paraplegia can also be seen in a variety of hereditary neurologic diseases with bilateral corticospinal tract impairment. The purpose of this study is to identify the disease spectrum of spastic paraplegia, and to broaden the coverage of genetic testing and recognize clinical, laboratorial, electrophysiological and radiological characteristics to increase the positive rate of diagnosis. Methods: Twenty-seven cases were screened out to have definite or suspected pathogenic variants from clinically suspected HSP pedigrees through HSP-associated sequencing and/or expanded genetic testing. One case was performed for enzyme detection of leukodystrophy without next-generation sequencing. In addition, detailed clinical, laboratorial, electrophysiological and radiological characteristics of the 28 patients were presented. Results: A total of five types of hereditary neurological disorders were identified in 28 patients, including HSP (15/28), leukodystrophy (5/28), hereditary ataxia (2/28), methylmalonic acidemia/methylenetetrahydrofolate reductase deficiency (5/28), and Charcot-Marie-tooth atrophy (1/28). Patients in the HSP group had chronic courses, most of whom were lower limbs spasticity, mainly with axonal neuropathy, and thinning corpus callosum, white matter lesions and cerebellar atrophy in brain MRI. In the non-HSP groups, upper and lower limbs both involvement was more common. Patients with homocysteine remethylation disorders or Krabbe’s disease or autosomal recessive spastic ataxia of Charlevoix-Saguenay had diagnostic results in laboratory or imaging examination. A total of 12 new variants were obtained. Conclusions: HSP had widespread clinical and genetic heterogeneity, and leukodystrophy, hereditary ataxia, Charcot-Marie-Tooth atrophy and homocysteine remethylation disorders accounted for a significant proportion of the proposed HSP. These diseases had different characteristics in clinical, laboratorial, electrophysiological, and radiological aspects, which could help differential diagnosis. Genetic analysis could ultimately provide a clear diagnosis, and broadening the scope of genetic testing could improve the positive rate of diagnosis.Keywords
This publication has 56 references indexed in Scilit:
- Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanismsActa Neuropathologica, 2013
- Mutations, Clinical Findings and Survival Estimates in South American Patients with X-Linked AdrenoleukodystrophyPLOS ONE, 2012
- Novel mutations in the CYP7B1 gene cause hereditary spastic paraplegiaMovement Disorders, 2011
- Novel mutations of the SPG11 gene in hereditary spastic paraplegia with thin corpus callosumJournal of the Neurological Sciences, 2008
- Identification of the gene responsible for methylmalonic aciduria and homocystinuria, cblC typeNature Genetics, 2005
- Autosomal dominant hereditary spastic paraplegia: DHPLC-based mutation analysis ofSPG4 reveals eleven novel mutationsHuman Mutation, 2005
- Spinal xanthomatosis: a variant of cerebrotendinous xanthomatosisBrain, 1999
- Nerve conduction studies in adrenomyeloneuropathy.Journal of Neurology, Neurosurgery & Psychiatry, 1996
- Identification of a Two Base Pair Deletion in Five Unrelated Families with Adrenoleukodystrophy: A Possible Hot Spot for MutationsBiochemical and Biophysical Research Communications, 1994
- Association of demyelination with deficiency of cerebrospinal-fluid S-adenosylmethionine in inborn errors of methyl-transfer pathwayThe Lancet, 1991